Russell Investments Group’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $575K | Sell |
123,189
-8,498
| -6% | -$39.7K | ﹤0.01% | 2281 |
|
|
2025
Q1 | $723K | Buy |
131,687
+113,713
| +633% | +$624K | ﹤0.01% | 2165 |
|
|
2024
Q4 | $60.9K | Buy |
17,974
+16,848
| +1,496% | +$57.1K | ﹤0.01% | 2781 |
|
|
2024
Q3 | $3.21K | Buy |
1,126
+729
| +184% | +$2.08K | ﹤0.01% | 3302 |
|
|
2024
Q2 | $893 | Buy |
397
+195
| +97% | +$439 | ﹤0.01% | 3443 |
|
|
2024
Q1 | $446 | Buy |
+202
| New | +$446 | ﹤0.01% | 3220 |
|
|
2023
Q4 | – | Sell |
-119
| Closed | -$221 | – | 3318 |
|
|
2023
Q3 | $221 | Buy |
+119
| New | +$221 | ﹤0.01% | 3485 |
|
|
2021
Q3 | – | Sell |
-77,815
| Closed | -$316K | – | 3233 |
|
|
2021
Q2 | $316K | Hold |
77,815
| – | – | ﹤0.01% | 2763 |
|
|
2021
Q1 | $350K | Hold |
77,815
| – | – | ﹤0.01% | 2661 |
|
|
2020
Q4 | $382K | Hold |
77,815
| – | – | ﹤0.01% | 2535 |
|
|
2020
Q3 | $461K | Buy |
+77,815
| New | +$461K | ﹤0.01% | 2430 |
|